Edition:
United Kingdom

People: Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

42.25USD
19 Jul 2019
Change (% chg)

$-0.39 (-0.91%)
Prev Close
$42.64
Open
$42.85
Day's High
$42.95
Day's Low
$42.17
Volume
2,657,305
Avg. Vol
1,972,538
52-wk High
$43.65
52-wk Low
$31.57

Meredith, Ian 

Prof. Ian T. Meredith AM is Executive Vice President, Global Chief Medical Officer of the Company. In this role, he is responsible for leading clinical science and medical affairs across Boston Scientific and providing global leadership of the company's clinical trial strategy. Prior to joining Boston Scientific, Professor Meredith served as professor and director of MonashHeart, and executive director of the Monash Cardiovascular Research Centre at Monash University in Melbourne, Australia, from September 2005 to December 2016. Professor Meredith has over 25 years of experience as a clinical and interventional cardiologist and also served as director of the Cardiac Catheterization Laboratories and Interventional Cardiology. Professor Meredith has been a member of the Board of the National Heart Foundation (Australia) and a member of the Cardiac Society of Australia and New Zealand National Board. Professor Meredith received a Ph.D. from the Baker Institute in Melbourne and an Order of Australia (AM) in the General Division for service to medicine in the field of Cardiology as a clinician and researcher.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Mahoney

13,970,900

Daniel Brennan

3,665,820

Kevin Ballinger

2,841,490

Joseph Fitzgerald

4,036,320

Edward Mackey

3,818,020

Ian Meredith

--
As Of  31 Dec 2018